| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
68,788,000 |
| Market
Cap: |
2.16(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.19 - $52.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Arvinas is a biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins. Co. is developing ARV-110, a proteolysis targeting chimeras (PROTAC) targeted protein degrader targeting the androgen receptor protein for the treatment of men with metastatic castration-resistant prostate cancer. Co. is also developing ARV-471, a PROTAC targeted protein degrader targeting the estrogen receptor protein, or ER, for the treatment of patients with locally advanced or metastatic ER positive / HER2 negative breast cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
10,298 |
10,298 |
11,622 |
21,554 |
| Total Sell Value |
$484,521 |
$484,521 |
$516,810 |
$859,747 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
4 |
4 |
5 |
9 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ratcliffe Liam |
Director |
– • – |
2021-11-15 |
4 |
S |
$83.90 |
$1,806,469 |
I/I |
(21,284) |
541,391 |
|
19% |
|
| Ratcliffe Liam |
Director |
– • – |
2021-11-12 |
4 |
S |
$84.02 |
$3,386,461 |
I/I |
(39,869) |
562,675 |
|
24% |
|
| Ratcliffe Liam |
Director |
– • – |
2021-11-11 |
4 |
S |
$85.92 |
$5,156,393 |
I/I |
(59,799) |
602,544 |
|
25% |
|
| Ratcliffe Liam |
Director |
– • – |
2021-11-10 |
4 |
S |
$86.59 |
$1,178,188 |
I/I |
(13,358) |
662,343 |
|
24% |
|
| Ratcliffe Liam |
Director |
– • – |
2021-11-09 |
4 |
S |
$91.33 |
$3,035,861 |
I/I |
(33,008) |
675,701 |
|
29% |
|
| Ratcliffe Liam |
Director |
– • – |
2021-11-08 |
4 |
S |
$92.48 |
$7,655,882 |
I/I |
(81,054) |
708,709 |
|
27% |
|
| Ratcliffe Liam |
Director |
– • – |
2021-11-05 |
4 |
S |
$89.86 |
$3,039,319 |
I/I |
(33,094) |
789,763 |
|
27% |
|
| Ratcliffe Liam |
Director |
– • – |
2021-11-05 |
4 |
S |
$89.65 |
$2,275,362 |
D/D |
(24,923) |
0 |
|
27% |
|
| Ratcliffe Liam |
Director |
– • – |
2021-11-05 |
4 |
OE |
$22.06 |
$544,531 |
D/D |
18,423 |
24,923 |
|
- |
|
| Houston John G |
President and CEO |
• • – |
2021-11-01 |
4 |
AS |
$87.13 |
$3,525,724 |
D/D |
(40,000) |
832,333 |
|
-32% |
|
| Houston John G |
President and CEO |
• • – |
2021-11-01 |
4 |
OE |
$16.00 |
$640,000 |
D/D |
40,000 |
872,333 |
|
- |
|
| Shannon Timothy M |
Director |
– • – |
2021-09-07 |
4 |
S |
$87.98 |
$3,243,796 |
I/I |
(36,411) |
1,653,128 |
|
28% |
|
| Shannon Timothy M |
Director |
– • – |
2021-09-03 |
4 |
S |
$85.47 |
$2,770,146 |
I/I |
(32,387) |
1,689,539 |
|
24% |
|
| Shannon Timothy M |
Director |
– • – |
2021-09-02 |
4 |
S |
$85.42 |
$4,443,116 |
I/I |
(51,765) |
1,721,926 |
|
25% |
|
| Houston John G |
President and CEO |
• • – |
2021-09-02 |
4 |
OE |
$16.00 |
$75,040 |
D/D |
4,690 |
832,333 |
|
- |
|
| Shannon Timothy M |
Director |
– • – |
2021-09-01 |
4 |
S |
$85.67 |
$6,915,221 |
I/I |
(79,437) |
1,773,691 |
|
22% |
|
| Shannon Timothy M |
Director |
– • – |
2021-08-31 |
4 |
S |
$85.39 |
$5,078,151 |
I/I |
(59,355) |
1,853,128 |
|
18% |
|
| Shannon Timothy M |
Director |
– • – |
2021-08-30 |
4 |
S |
$85.19 |
$5,064,458 |
I/I |
(58,838) |
1,912,483 |
|
18% |
|
| Shannon Timothy M |
Director |
– • – |
2021-08-27 |
4 |
S |
$85.38 |
$3,845,951 |
I/I |
(45,026) |
1,971,321 |
|
19% |
|
| Shannon Timothy M |
Director |
– • – |
2021-08-26 |
4 |
S |
$85.12 |
$996,970 |
I/I |
(11,712) |
2,016,347 |
|
17% |
|
| Margus Bradley Albert |
Director |
– • – |
2021-08-26 |
4 |
S |
$85.03 |
$845,168 |
I/I |
(9,940) |
2,000 |
|
17% |
|
| Shannon Timothy M |
Director |
– • – |
2021-08-25 |
4 |
S |
$85.03 |
$1,213,144 |
I/I |
(14,267) |
2,028,059 |
|
16% |
|
| Margus Bradley Albert |
Director |
– • – |
2021-08-25 |
4 |
S |
$85.00 |
$1,700,000 |
I/I |
(20,000) |
11,940 |
|
16% |
|
| Shannon Timothy M |
Director |
– • – |
2021-08-24 |
4 |
S |
$86.95 |
$800,818 |
I/I |
(9,203) |
2,042,326 |
|
7% |
|
| Shannon Timothy M |
Director |
– • – |
2021-08-23 |
4 |
S |
$88.01 |
$140,728 |
I/I |
(1,599) |
2,051,529 |
|
7% |
|
174 Records found
|
|
Page 3 of 7 |
|
|
0.21 (0.67%) 
